{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24629333",
  "DateCompleted": {
    "Year": "2014",
    "Month": "11",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.chom.2014.01.002",
      "S1931-3128(14)00025-0"
    ],
    "Journal": {
      "ISSN": "1934-6069",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "3",
        "PubDate": {
          "Year": "2014",
          "Month": "Mar",
          "Day": "12"
        }
      },
      "Title": "Cell host & microbe",
      "ISOAbbreviation": "Cell Host Microbe"
    },
    "ArticleTitle": "Viruses for tumor therapy.",
    "Pagination": {
      "StartPage": "260",
      "EndPage": "265",
      "MedlinePgn": "260-5"
    },
    "Abstract": {
      "AbstractText": [
        "Oncolytic virotherapy exploits live viruses with selective tropism for cancerous cells and tissues to treat cancer. As discussed here, the field has progressed considerably as a result of both the successes and failures of previous and on-going clinical trials for various cancers. These studies indicate that oncolytic viruses are remarkably safe and more efficacious when virus replication stimulates sustained antitumor immune responses. In the future, virotherapy should be combined with immunomodulatory reagents that target immune tolerance to established cancers."
      ],
      "CopyrightInformation": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Cancer Therapeutics, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada."
          }
        ],
        "LastName": "Bell",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL 32610, USA. Electronic address: grantmcf@ufl.edu."
          }
        ],
        "LastName": "McFadden",
        "ForeName": "Grant",
        "Initials": "G"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R01 AI080607",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI100987",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA138541",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "Acronym": "CAPMC",
        "Agency": " CIHR",
        "Country": "Canada"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Host Microbe",
    "NlmUniqueID": "101302316",
    "ISSNLinking": "1931-3128"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunologic Factors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunologic Factors"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Oncolytic Virotherapy"
    },
    {
      "QualifierName": [
        "growth & development",
        "physiology"
      ],
      "DescriptorName": "Oncolytic Viruses"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Tropism"
    }
  ]
}